SPDR S&P Biotech ETF Rating $85.60 -3.11 (-3.51%) Closing price 04:10 PM EasternExtended Trading$85.64 +0.04 (+0.05%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.77Holdings in XBI have an aggregate rating of Moderate Buy based on 758 analyst ratings issued in the past year covering 50 companies (77.1% of the portfolio).XBI Aggregate Price Target$85.60High Prediction$85.60Average Prediction$85.60Low Prediction$85.60Holdings in XBI have an aggregate price target of $85.60 and a range of $85.60 to $85.60 covering 50 companies (77.1% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.95%GILDGilead Sciences$115.99+1.5%4.7655 of 5 stars2.72$102.08 -12.0%29Analyst RevisionPositive News2.86%ABBVAbbVie$211.27+1.1%4.5998 of 5 stars2.88$208.35 -1.4%24Insider TradePositive News2.82%AMGNAmgen$310.78+0.9%4.2461 of 5 stars2.46$314.09 1.1%24Options VolumeAnalyst RevisionPositive News2.64%BMRNBioMarin Pharmaceutical$71.02-0.2%4.9803 of 5 stars2.71$94.00 32.4%24Analyst Downgrade2.56%INSMInsmed$76.29-6.5%3.9763 of 5 stars3.00$91.60 20.1%162.51%INCYIncyte$70.26-4.4%4.4502 of 5 stars2.32$75.25 7.1%19Insider TradePositive News2.51%VRTXVertex Pharmaceuticals$483.31+0.7%3.9538 of 5 stars2.65$506.70 4.8%26Insider TradePositive News2.42%UTHRUnited Therapeutics$310.03-3.1%4.9087 of 5 stars2.67$388.25 25.2%12Earnings ReportAnalyst RevisionPositive News2.36%ALNYAlnylam Pharmaceuticals$243.53-1.3%4.2783 of 5 stars2.72$304.26 24.9%252.29%REGNRegeneron Pharmaceuticals$684.87-2.0%4.7578 of 5 stars2.76$973.13 42.1%252.29%HALOHalozyme Therapeutics$57.96-2.0%4.3409 of 5 stars2.60$62.78 8.3%10Insider Trade2.28%NTRANatera$143.11-8.0%3.4992 of 5 stars3.00$172.69 20.7%16Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionHigh Trading Volume2.23%BIIBBiogen$141.71+0.9%4.7213 of 5 stars2.43$213.33 50.5%302.21%NBIXNeurocrine Biosciences$114.48-3.6%4.9263 of 5 stars2.83$166.90 45.8%23Buyback AnnouncementShort Interest ↑2.13%PCVXVaxcyte$72.10-1.3%2.223 of 5 stars3.00$147.50 104.6%9Earnings ReportAnalyst Revision2.09%SRPTSarepta Therapeutics$101.22-5.2%4.5739 of 5 stars2.86$173.52 71.4%221.94%EXASExact Sciences$47.55+0.3%4.4609 of 5 stars2.95$71.94 51.3%191.90%MRNAModerna$30.27-2.2%4.5064 of 5 stars2.04$60.63 100.3%231.87%MDGLMadrigal Pharmaceuticals$313.47-8.1%3.9716 of 5 stars2.85$375.75 19.9%13Earnings ReportInsider TradeAnalyst Revision1.76%TGTXTG Therapeutics$34.42+14.4%3.936 of 5 stars2.83$40.67 18.1%6Earnings ReportOptions VolumeNews CoverageHigh Trading Volume1.57%BBIOBridgeBio Pharma$33.01-5.4%4.7065 of 5 stars2.92$51.67 56.5%13Analyst Revision1.48%BPMCBlueprint Medicines$89.75-7.1%2.8408 of 5 stars2.65$123.83 38.0%20Analyst Forecast1.44%ADMAADMA Biologics$15.83-3.4%3.0907 of 5 stars3.25$21.25 34.2%4Earnings ReportPositive News1.43%EXELExelixis$38.55-0.4%4.1869 of 5 stars2.50$37.24 -3.4%20Insider TradeShort Interest ↑1.41%CYTKCytokinetics$42.89-6.8%3.9629 of 5 stars2.94$82.00 91.2%18Earnings ReportAnalyst ForecastAnalyst Revision1.40%VKTXViking Therapeutics$25.70-11.0%4.4572 of 5 stars3.00$97.29 278.5%151.38%IONSIonis Pharmaceuticals$32.60-1.8%4.4707 of 5 stars2.70$60.00 84.0%201.36%ROIVRoivant Sciences$10.17-5.3%2.281 of 5 stars3.00$18.08 77.8%71.35%CRSPCRISPR Therapeutics$42.29-3.7%3.4447 of 5 stars2.50$74.40 75.9%22Insider TradeGap Up1.33%ALKSAlkermes$34.11-0.6%4.0809 of 5 stars2.82$38.36 12.5%11Positive News1.30%RVMDRevolution Medicines$38.34-5.9%4.6546 of 5 stars3.08$66.31 72.9%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.21%SWTXSpringWorks Therapeutics$53.28-7.8%2.4695 of 5 stars3.00$73.20 37.4%5Short Interest ↓1.18%APLSApellis Pharmaceuticals$24.06-4.3%3.8901 of 5 stars2.63$45.71 90.0%19Earnings ReportAnalyst ForecastNews Coverage1.03%SMMTSummit Therapeutics$19.13-7.5%2.5734 of 5 stars2.88$34.63 81.0%8Earnings ReportAnalyst ForecastAnalyst Revision0.94%RNAAvidity Biosciences$29.22-4.6%1.1198 of 5 stars3.00$65.20 123.1%10Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Down0.90%KRYSKrystal Biotech$171.83-4.1%4.6224 of 5 stars3.00$215.83 25.6%7Earnings ReportAnalyst ForecastInsider TradePositive News0.90%BHVNBiohaven$31.93-14.1%3.4803 of 5 stars3.07$63.15 97.8%15Earnings ReportUpcoming EarningsNews CoverageHigh Trading Volume0.88%RXRXRecursion Pharmaceuticals$6.59-12.3%2.2939 of 5 stars2.40$8.25 25.2%5Earnings ReportAnalyst ForecastGap Up0.82%NUVLNuvalent$71.03-5.3%2.1084 of 5 stars2.85$113.10 59.2%13Earnings ReportAnalyst Forecast0.81%ACLXArcellx$62.63-3.4%2.0006 of 5 stars3.13$108.46 73.2%15Earnings ReportAnalyst Revision0.75%RAREUltragenyx Pharmaceutical$41.26-3.9%4.5415 of 5 stars2.93$93.50 126.6%14Insider Trade0.72%PTCTPTC Therapeutics$52.87-4.3%3.7226 of 5 stars2.50$62.08 17.4%14Analyst ForecastAnalyst Revision0.69%TWSTTwist Bioscience$37.11-4.4%4.3009 of 5 stars2.70$54.40 46.6%10Positive News0.66%TVTXTravere Therapeutics$19.80-7.5%2.5298 of 5 stars2.93$30.62 54.6%140.63%AKROAkero Therapeutics$45.54-7.3%4.1623 of 5 stars3.00$76.29 67.5%9Earnings ReportAnalyst ForecastShort Interest ↑News CoverageGap Down0.61%PTGXProtagonist Therapeutics$38.50+2.4%3.7019 of 5 stars3.00$55.44 44.0%9Analyst ForecastNews CoverageGap UpHigh Trading Volume0.61%DVAXDynavax Technologies$13.53-1.9%3.9862 of 5 stars2.33$21.50 58.9%30.60%BEAMBeam Therapeutics$25.10-4.7%3.6779 of 5 stars2.92$51.00 103.2%13Earnings ReportAnalyst ForecastAnalyst Revision0.58%CLDXCelldex Therapeutics$19.35-5.9%1.1821 of 5 stars2.88$55.38 186.2%8Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up0.55%FOLDAmicus Therapeutics$9.13-3.8%4.4202 of 5 stars2.78$16.75 83.5%9Short Interest ↓Positive News This page (NYSEARCA:XBI) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBI Stock Alerts